This Article Full Text Full Text (PDF) All Versions of this Article: 38/3/1057    most recent 01.STR.0000257978.70312.1dv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tsubokawa, T. Articles by Zhang, J. H. Search for Related Content PubMed PubMed Citation Articles by Tsubokawa, T. Articles by Zhang, J. H. Related Collections Animal models of human disease Apoptosis Acute Cerebral Infarction Neuroprotectors

(Stroke. 2007;38:1057.)
© 2007 American Heart Association, Inc.

Original Contributions

Lecithinized Superoxide Dismutase Improves Outcomes and Attenuates Focal Cerebral Ischemic Injury via Antiapoptotic Mechanisms in Rats

Tamiji Tsubokawa, MD, PhD; Vikram Jadhav, MB, BS, PhD; Ihsan Solaroglu, MD; Yoshiaki Shiokawa, MD, PhD; Yoshifumi Konishi, MD, PhD John H. Zhang, MD, PhD

From the Departments of Physiology and Pharmacology (T.T., V.J., I.S., J.Z.), Neurosurgery (J.Z.), and Anesthesiology (J.Z.), Loma Linda University School of Medicine, Loma Linda, Calif, and the Department of Neurosugery (Y.S., Y.K.), Kyorin University School of Medicine, Tokyo, Japan.

Correspondence to John H. Zhang MD, PhD, Division of Neurosurgery, Loma Linda University Medical Center, 11234 Anderson St, Rm 2562B, Loma Linda, CA 92354. E-mail johnzhang3910{at}yahoo.com

Background and Purpose— Recent studies have shown the antiapoptotic neuroprotective effects of lecithinized superoxide dismutase (PC-SOD) in different forms of brain injury. We tested the effects of PC-SOD in focal cerebral ischemia in the rat middle cerebral artery occlusion model (MCAO).

Methods— Adult male Sprague-Dawley rats were treated with PC-SOD (0.3, 1.0, and 3.0 mg/kg) administered intravenously after 90 minutes of occlusion (beginning of reperfusion). Physiological parameters, neurological score, and infarct volume were assessed at 24 and 72 hours in 3 groups of animals: sham-operated (n=18), MCAO treated with vehicle (n=26), and MCAO treated with PC-SOD (n=37). Oxidative stress was evaluated by malondialdehyde assay, and the apoptotic mechanisms were studied by Western blotting.

Results— PC-SOD treatment significantly reduced infarct volume and improved neurological scores at different time points compared with the vehicle-treated group. PC-SOD treatment decreased malondialdehyde levels, cytochrome c, and cleaved caspase 3 expression and increased mitochondrial Bcl-2 expression.

Conclusions— Inhibition of oxidative stress with PC-SOD treatment improves outcomes after focal cerebral ischemia. This neuroprotective effect is likely exerted by antiapoptotic mechanisms.

Key Words: cerebral ischemia • lecithinized superoxide dismutase • neuronal apoptosis • oxidative stress

This article has been cited by other articles:

				M. K. Reddy and V. Labhasetwar Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury FASEB J, May 1, 2009; 23(5): 1384 - 1395. [Abstract] [Full Text] [PDF]

				T. Ishihara, K.-I. Tanaka, Y. Tasaka, T. Namba, J. Suzuki, T. Ishihara, S. Okamoto, T. Hibi, M. Takenaga, R. Igarashi, et al. Therapeutic Effect of Lecithinized Superoxide Dismutase against Colitis J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 152 - 164. [Abstract] [Full Text] [PDF]

				B. Xing, H. Chen, M. Zhang, D. Zhao, R. Jiang, X. Liu, and S. Zhang Ischemic Postconditioning Inhibits Apoptosis After Focal Cerebral Ischemia/Reperfusion Injury in the Rat Stroke, August 1, 2008; 39(8): 2362 - 2369. [Abstract] [Full Text] [PDF]

				J. Suzuki, F. Broeyer, A. Cohen, M. Takebe, J. Burggraaf, and Y. Mizushima Pharmacokinetics of PC-SOD, a Lecithinized Recombinant Superoxide Dismutase, After Single- and Multiple-Dose Administration to Healthy Japanese and Caucasian Volunteers J. Clin. Pharmacol., February 1, 2008; 48(2): 184 - 192. [Abstract] [Full Text] [PDF]